Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
7.21M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
505K
-
Shares change
-
+438K
-
Total reported value, excl. options
-
$399K
-
Value change
-
+$317K
-
Number of buys
-
3
-
Number of sells
-
-8
-
Price
-
$0.79
Significant Holders of BIO KEY INTERNATIONAL INC - Common Stock, $0.0001 par value per share (BKYI) as of Q1 2025
15 filings reported holding BKYI - BIO KEY INTERNATIONAL INC - Common Stock, $0.0001 par value per share as of Q1 2025.
BIO KEY INTERNATIONAL INC - Common Stock, $0.0001 par value per share (BKYI) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 505K shares
of 7.21M outstanding shares and own 7.01% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (440K shares), TWO SIGMA SECURITIES, LLC (25.4K shares), GEODE CAPITAL MANAGEMENT, LLC (21.7K shares), Virtu Financial LLC (14.8K shares), Tower Research Capital LLC (TRC) (1.8K shares), CITIGROUP INC (428 shares), SBI Securities Co., Ltd. (300 shares), OSAIC HOLDINGS, INC. (262 shares), BANK OF AMERICA CORP /DE/ (24 shares), and HARBOUR INVESTMENTS, INC. (6 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.